A phase I trial to investigate sumatriptan (CL-H1T) in patients with migraine pain and migraine-induced nausea or vomiting

Trial Profile

A phase I trial to investigate sumatriptan (CL-H1T) in patients with migraine pain and migraine-induced nausea or vomiting

Recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Promethazine/sumatriptan (Primary)
  • Indications Migraine; Nausea and vomiting
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Aug 2015 Status changed from planning to recruiting according to a Charleston Laboratories media release.
    • 14 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top